Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:10405-02-4
Molecular Formula:C25H30ClNO3
Alias
More Information
2-Hydroxy-2,2-Diphenylacetic Acid [(1S,5R)-3-Spiro[8-Azoniabicyclo[3.2.1]Octane-8,1'-Azolidin-1-Ium]Yl] Ester Chloride; (1A,3,5A)-3-[(2-Hydroxy-2,2-Diphenylacetyl)Oxy]-Spiro[8-Azoniabicyclo[3.2.1]Octane-8,1'-Pyrrolidinium] Chloride; 5-Alpha-H-Nortropane-8,1'-Pyrrolidinium),3-Alpha-Hydroxy-Spiro(1-Alpha-Chl; 8-Alpha-Benziloyloxy-6,10-Ethano-5-Azoniaspiro(4.5)Decanechloride; Asxvii; Azoniaspiro(3-Alpha-Benziloyloxy-Nortropan-8,1'-Pyrrolidine)-Chloride; Azoniaspirocompoundxvii; Keptan
Brief Introduction
Anticholinergic drugs are used to treat bladder overactivity disorders such as urinary incontinence, urgency, and frequency.
CAS:106308-44-5
Molecular Formula:C10H8F2N4O
Alias
More Information
Banzel; Inovelon; 1-(2,6-Difluorobenzyl)-1H-1,2,3-Triazole-4-Carboxamide; 1-[(2,6-Difluorophenyl)Methyl]-1H-1,2,3-Triazole-4-Carboxamide; 1-[(2,6-Difluorophenyl)Methyl]Triazole-4-Carboxamide; C10H8F2N4O; 1H-1,2,3-Triazole-4-Carboxamide, 1-[(2,6-Difluorophenyl)Methyl]-; 1H-1,2,3-Triazole-4-Carboxamide, 1-((2,6-Difluorophenyl)Methyl)-; 1-[(2,6-Difluorophenyl)Methyl]-1H-1,2,3-Triazole-4 Carboxamide; Rufinamide (Banzel); Rufinamide, >=98% (HPLC), Powder; 1-[(2,6-Difluorophenyl)Methyl]-4-Triazolecarboxamide; 1-(2,6-Difluorobenzyl)-1H-1,2,3-Triazol-4-Carboxamide; Rufinamide, United States Pharmacopeia (USP) Reference Standard; 1-[[2,6-bis(Fluoranyl)Phenyl]Methyl]-1,2,3-Triazole-4-Carboxamide
Brief Introduction
Rufinamide is an antiepileptic triazole derivative that reduces the firing of sodium channel neurons. Used as an anticonvulsant, a neuroprotective and neuroresearch product.
CAS:1078-21-3
Molecular Formula:C10H13NO2
Alias
More Information
Benzenepropanoic acid, β-(Aminomethyl)-, Hydrochloride (1:1); 4-Amino-3-Phenylbutanoic acid Hydrochloride (1:1); 4-Amino-3-Phenylbutyric acid Hcl; Fenigam; Phenylgam; Phenybut; Phenigam; Fenigama; Pgaba; Phenibut; Fenibut; Phenigama; Phenygam; 4-Amino-3-Phenylbutanoicacidhydrochloride; 4-Amino-3-Phenylbutiricacid; NAME?; 4-Amino-3-Phenylbutyricacidhydrochloride; 4-Amino-3-Phenylbutanoic acid; 4-Amino-3-Phenylbutyric acid; Phenylgamma; Phgaba; beta-Phenyl-Gamma-Aminobutyric acid; beta-(Aminomethyl)Hydrocinnamic acid; beta-Phenyl-Gamma-Aminobutyrate; 4-Amino-3-Phenyl-Butyric acid; beta-(Aminomethyl)Benzenepropanoic acid; Benzenepropanoic acid, .beta.-(Aminomethyl)-; Benzenepropanoic acid, beta-(Aminomethyl)-; 4-Amino-3-Pheny-Butyric acid; Phenyl-GABA; Phenigamma; Benzenepropanoic acid, beta-(Aminomethyl)-, Hydrochloride; Butyric ACID, 4-Amino-3-Phenyl-; 3-Phenyl-4-Aminobutanoic acid; Dl-4-Amino-3-Phenylbutanoic acid; (S)-4-Amino-3-Phenylbutanoicacid; 3-Amino-2-Phenylpropanecarboxylic acid; Benzenepropanoic acid, b-(Aminomethyl)-
Brief Introduction
4-Amino-3-Phenylbutyric acid Hydrochloride is mainly used as an antidepressant
CAS:1256388-51-8
Molecular Formula:C49H54F2N8O6
Alias
More Information
Methyl N-[(2S)-1-[(6S)-6-[5-[9,9-Difluoro-7-[2-[(1S,2S,4R)-3-[(2S)-2-(Methoxycarbonylamino)-3-Methylbutanoyl]-3-Azabicyclo[2.2.1]Heptan-2-Yl]-3H-Benzimidazol-5-Yl]Fluoren-2-Yl]-1H-Imidazol-2-Yl]-5-Azaspiro[2.4]Heptan-5-Yl]-3-Methyl-1-Oxobutan-2-Yl]Carbamate; Ledipasvir Acetonate;
Brief Introduction
For the treatment of hepatitis C virus infection.
CAS:1421373-65-0
Molecular Formula:C28H33N7O2
Alias
More Information
Osimertinib; AZD9291; Mereletinib; N-[2-[2-(Dimethylamino)Ethyl-Methylamino]-4-Methoxy-5-[[4-(1-Methylindol-3-yl)Pyrimidin-2-yl]Amino]Phenyl]prop-2-Enamide; Tagrisso; Osimertinib (AZD9291); Osimerthihib; Osimerthihib 80; Tagrisso 80
Brief Introduction
Osimertinib (previously known as mereletinib or AZD9291; trade name Tagrisso) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) drug developed by AstraZeneca Pharmaceuticals – for mutated EGFR cancers.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!